Abstract
Severe donor shortage in Japan makes the waiting period for heart transplantation extremely long and the left ventricular assist devices (LVADs) are often used for bridge-to-transplant. We present three cases of infected and exposed DuraHeart® LVAD system treated with free flaps. Four free flaps (two latissimus flaps and two anterolateral thigh flaps) were transferred using the right internal thoracic vessels or left deep inferior epigastric vessels as recipients. The potential significance of the continuous low pressure blood flow generated by the LVAD system on microvascular patency has not been previously reported. All flaps survived and worked efficiently to control the infection and cover the devices. Heart transplantation was conducted in the two of three patients. Free flap transfer is an efficient treatment for the patients with infected and exposed implantable LVAD.
Similar content being viewed by others
References
Kitamura S. Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg. 2012;60:639–44.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
Schulman AR, Martens TP, Russo MJ, Christos PJ, Gordon RJ, Lowy FD, et al. Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant. 2009;28:237–42.
Shafii AE, Chamogeorgakis TP, Gonzalez-Stawinski G. Omental flap transposition with intra-abdominal relocation for LVAD pump-pocket infection. J Heart Lung Transplant. 2011;30:1421–2.
Hutchinson OZ, Oz MC, Ascherman JA. The use of muscle flaps to treat left ventricular assist device infections. Plast Reconstr Surg. 2001;107:364–73.
Kimura M, Nishimura T, Kinoshita O, Okada S, Inafuku H, Kyo S, et al. Successful treatment of pump pocket infection after left ventricular assist device implantation by negative pressure wound therapy and omental transposition. Ann Thorac Cardiovasc Surg. 2013. doi:10.5761/atcs.cr.12.02192.
Kawata M, Nishimura T, Hoshino Y, Kinoshita O, Hisagi M, Ando M, et al. Negative pressure wound therapy for left ventricular assist device-related mediastinitis: two case reports. J Artif Organs. 2011;14:159–62.
Nishinaka T, Schima H, Roethy W, Rajek A, Nojiri C, Wolner E, et al. The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience. Circ J. 2006;70:1421–5.
Rossi M, Serraino GF, Jiritano F, Renzulli A. What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg. 2012;15:733–40.
Slaughter MS. Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res. 2010;3:618–24.
Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29:717–27.
Suma H, Fukumoto H, Takeuchi A. Coronary artery bypass grafting by utilizing in situ right gastroepiploic artery: basic study and clinical application. Ann Thorac Surg. 1987;44:394–7.
Korewicki J, Leszek P, Zielinski T, Rywik T, Piotrowski W, Kurjata P, et al. Severe chronic heart failure in patients considered for heart transplantation in Poland. Cardiol J. 2012;19:36–44.
Acknowledgments
We thank Professor WA Morrison, Director of the O’Brien Institute, Melbourne, Australia, for his advice in preparing this manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsuda, K., Nishibayashi, A., Toda, K. et al. Covering implantable left ventricular assist device (DuraHeart®) with free flap. J Artif Organs 18, 114–119 (2015). https://doi.org/10.1007/s10047-014-0812-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-014-0812-y